Westpac Banking Corp’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-50,655
Closed -$10.8M 996
2014
Q4
$10.8M Buy
50,655
+11,200
+28% +$2.23M 0.1% 207
2014
Q3
$7.03M Sell
39,455
-12,115
-23% -$2.01M 0.07% 265
2014
Q2
$8.73M Buy
51,570
+31,420
+156% +$4.89M 0.08% 238
2014
Q1
$2.5M Buy
20,150
+2,026
+11% +$247K 0.03% 442
2013
Q4
$2.01M Hold
18,124
0.02% 483
2013
Q3
$1.64M Sell
18,124
-1,109
-6% -$99.6K 0.02% 481
2013
Q2
$1.81M Buy
+19,233
New +$2M 0.03% 428

Other funds holding AGN

Westpac Banking Corp's AGN Position: Q1 2015 in Review

Westpac Banking Corp sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 50,655 shares — an estimated $10.8M sold.

Westpac Banking Corp first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $10.8M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Westpac Banking Corp reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Westpac Banking Corp sold 50,655 Allergan Inc shares in Q1 2015, an estimated $10.8M.
  • Westpac Banking Corp first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Westpac Banking Corp's Allergan Inc position peaked at $10.8M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Westpac Banking Corp's 13F filing for Q1 2015, filed 12 May 2015.